Development of bacterial vectors for tumor-targeted gene therapy

Methods in Molecular Biology

Volumn 542, Issue , 2009, Pages 131-154

  Jia, Li Jun ^a,b   Hua, Zi Chun ^a  

^a NANJING UNIVERSITY   (China)

^b UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

Author keywords

Administration routes; anti angiogenesis; bacterial vector; cancer gene therapy; cytokine; gene expression; prodrug therapy; RNA interference; tumor targeting

Indexed keywords

BACTERIA (MICROORGANISMS);

BACTERIAL DNA;

ANIMAL; ANTIBODY SPECIFICITY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; METHODOLOGY; NEOPLASM; REVIEW;

ANIMALS; DNA, BACTERIAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; NEOPLASMS; ORGAN SPECIFICITY;

EID: 67650337790     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_7     Document Type: Review

References (108)

1. Cross D , Burmester JK . (2006) Gene therapy for cancer treatment: Past, present and future . Clin Med Res . 4 : 218-27 .
2. Palmer DH , Young LS , Mautner V . (2006) Cancer gene-therapy: Clinical trials . Trends Biotechnol . 24 : 76-82 .
3. Seth P . (2005) Vector-mediated cancer gene therapy: An overview . Cancer Biol Ther . 4 : 512-7 .
4. Dong JY , Woraratanadharm J . (2005) Gene therapy vector design strategies for the treatment of cancer . Future Oncol . 1 : 361-73 .
5. Möse JR , Möse G . (1964) Oncolysis by Clostridia . I. Activity of Clostridium Butyricum (M-55) and Other nonpathogenic Clostridia against the Ehrlich carcinoma . Cancer Res . 24 : 212-6
6. Gericke D and Engelbart K. (1964) Oncolysis by Clostridia. II. Experiments on a Tumor Spectrum With a Variety of Clostridia in Combination with Heavy Metal . Cancer Res. 24 : 217-221
7. Kimura NT , Taniguchi S , Aoki K , Baba T . (1980) Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration . Cancer Res . 40 : 2061-8 .
8. Pawelek JM , Low KB , Bermudes D . (1997) Tumor-targeted Salmonella as a novel anticancer vector . Cancer Res . 57 : 4537-44 .
9. Sznol M , Lin SL , Bermudes D , Zheng LM , King I . (2000) Use of preferentially replicating bacteria for the treatment of cancer . J Clin Invest . 105 : 1027-30 .
10. Bermudes D , Low KB , Pawelek J , Feng M , Belcourt M , Zheng LM , King I . (2001) Tumour-selective Salmonella-based cancer therapy . Biotechnol Genet Eng Rev . 18 : 219-33 .
11. Pawelek JM , Low KB , Bermudes D . (2003) Bacteria as tumour-targeting vectors . Lancet Oncol . 4 : 548-56 .
12. Ryan RM , Green J , Lewis CE . (2006) Use of bacteria in anti-cancer therapies . Bioessays . 28 : 84-94 .
13. Schmidt W , Fabricius EM , Schneeweiss U . (2006) The tumour-Clostridium phenomenon: 50 years of developmental research . Int J Oncol . 29 : 1479-92 .
14. Mengesha A , Dubois L , Chiu RK , Paesmans K , Wouters BG , Lambin P , Theys J . (2007) Potential and limitations of bacterial-mediated cancer therapy . Front Biosci . 12 : 3880-91 .
15. Brown JM , Wilson WR . (2004) Exploiting tumour hypoxia in cancer treatment . Nat Rev Cancer . 4 : 437-47 .
16. Zhou J , Schmid T , Schnitzer S , Brune B . (2006) Tumor hypoxia and cancer progression . Cancer Lett . 237 : 10-21 .
17. Dang LH , Bettegowda C , Huso DL , Kinzler KW , Vogelstein B . (2001) Combination bacteriolytic therapy for the treatment of experimental tumors . Proc Natl Acad Sci . 98 : 15155-60 .
18. Agrawal N , Bettegowda C , Cheong I , Geschwind JF , Drake CG , Hipkiss EL , Tatsumi M , Dang LH , Diaz LA Jr , Pomper M , Abusedera M , Wahl RL , Kinzler KW , Zhou S , Huso DL , Vogelstein B . (2004) Bacteriolytic therapy can generate a potent immune response against experimental tumors . Proc Natl Acad Sci USA . 101 : 15172-7 .
19. Avogadri F , Martinoli C , Petrovska L , Chiodoni C , Transidico P , Bronte V , Longhi R , Colombo MP , Dougan G , Rescigno M . (2005) Cancer immunotherapy based on killing of Salmonella-infected tumor cells . Cancer Res . 65 : 3920-7
20. Jia LJ , Wei DP , Sun QM , Jin GH , Li SF , Huang Y , Hua ZC . (2007) Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model . Int J Cancer . 121 : 666-74 .
21. Lee CH, Wu CL, Shiau AL. (2008) Salmonella choleraesuis as an anticancer agent in a syngeneic model of orthotopic hepatocellular carcinoma. Int J Cancer. 122:930-5 .
22. Rosenberg SA , Spiess PJ , Kleiner DE . (2002) Antitumor effects in mice of the intravenous injection of attenuated Salmonella typhimurium . J Immunother . 25 : 218-25 .
23. Rintoul RC , Sethi T . (2001) The role of extracellular matrix in small-cell lung cancer . Lancet Oncol . 2 : 437-42
24. Zhou S , Bettegowda C , Agrawal N . (2004) combination bacteriolytic cancer therapy: Attacking cancer form inside out . Discov Med . 4 : 33-37
25. Waehler R , Russell SJ , Curiel DT . (2007) Engineering targeted viral vectors for gene therapy . Nat Rev Genet . 8 : 573-87 .
26. Bettegowda C , Huang X , Lin J , Cheong I , Kohli M , Szabo SA , Zhang X , Diaz LA Jr , Velculescu VE , Parmigiani G , Kinzler KW , Vogelstein B , Zhou S . (2006) The genome and transcriptomes of the anti-tumor agent Clostridium novyi -NT . Nat Biotechnol . 24 : 1573-80 .
27. Baker S , Dougan G . (2007) The genome of Salmonella enterica serovar Typhi . Clin Infect Dis . 45 : S29 - 33 .
28. Low KB , Ittensohn M , Le T , Platt J , Sodi S , Amoss M , Ash O , Carmichael E , Chakraborty A , Fischer J , Lin SL , Luo X , Miller SI , Zheng L , King I , Pawelek JM , Bermudes D . (1999) Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo . Nat Biotechnol . 17 : 37-41 .
29. Toso JF , Gill VJ , Hwu P , Marincola FM , Restifo NP , Schwartzentruber DJ , Sherry RM , Topalian SL , Yang JC , Stock F , Freezer LJ , Morton KE , Seipp C , Haworth L , Mavroukakis S , White D , MacDonald S , Mao J , Sznol M , Rosenberg SA . (2002) Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma . J Clin Oncol . 20 : 142-52 .
30. Low KB , Ittensohn M , Luo X , Zheng LM , King I , Pawelek JM , Bermudes D . (2004) Construction of VNP20009: A novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans . Methods Mol Med . 90 : 47-60 .
31. Diaz LA Jr , Cheong I , Foss CA , Zhang X , Peters BA , Agrawal N , Bettegowda C , Karim B , Liu G , Khan K , Huang X , Kohli M , Dang LH , Hwang P , Vogelstein A , Garrett-Mayer E , Kobrin B , Pomper M , Zhou S , Kinzler KW , Vogelstein B , Huso DL . (2005) Pharmacologic and toxicologic evaluation of C. novyi -NT spores . Toxicol Sci . 88 : 562-75 .
32. Cunningham C , Nemunaitis J. (2001) A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPETCD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with adVanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001 . Hum Gene Ther 12 : 1594-6
33. Carey R , Holland J , Whang H , Neter E , Bryant B. (1967) Clostridial oncolysis in man . Eur J Cancer . 3 , 37-46
34. Heppner F , Mose JR . (1978) The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium . Acta Neurochir . 42 : 123-5
35. Luo X , Li Z , Lin S , Le T , Ittensohn M , Bermudes D , Runyab JD , Shen SY , Chen J , King IC , Zheng LM . (2001) Antitumor effect of VNP20009, an attenuated Salmonella, in murine tumor models . Oncol Res . 12 : 501-8 .
36. Zhao M , Geller J , Ma H , Yang M , Penman S , Hoffman RM . (2007) Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer . Proc Natl Acad Sci USA . 104 : 10170-4 .
37. Lambin P , Theys J , Landuyt W , Rijken P , Van der Kogel A , Van der Schueren E , Hodgkiss R , Fowler J , Nuyts S , de Bruijn E , Van Mellaert L , Anne J . (1998) Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours . Anaerobe . 4 : 183-8 .
38. Yazawa K , Fujimori M , Amano J , Kano Y , Taniguchi S . (2000) Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors . Cancer Gene Ther . 7 : 269-74 .
39. Portsmouth D , Hlavaty J , Renner M . (2007) Suicide genes for cancer therapy . Mol Aspects Med . 28 : 4-41 .
40. Xu G , McLeod HL . (2001) Strategies for enzyme/prodrug cancer therapy . Clin Cancer Res . 7 : 3314-24 .
41. Fox ME , Lemmon MJ , Mauchline ML , Davis TO , Giaccia AJ , Minton NP , Brown JM . (1996) Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered clostridia . Gene Ther . 3 : 173-8 .
42. Lemmon MJ , Van Zijl P , Fox ME , Mauchline ML , Giaccia AJ , Minton NP , Brown JM . (1997) Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment . Gene Ther . 4 : 791-6 .
43. Theys J , Landuyt W , Nuyts S , Van Mellaert L , Van Oosterom A , Lambin P , Anne J . (2001) Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum . Cancer Gene Ther . 8 : 294-7 .
44. Nuyts S , Theys J , Landuyt W , Van Mellaert L , Lambin P , Anne J . (2001) Increasing specificity of anti-tumor therapy: Cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters . Anticancer Res . 21 : 857-61 .
45. Theys J , Pennington O , Dubois L , Anlezark G , Vaughan T , Mengesha A , Landuyt W , Anne J , Burke PJ , Durre P , Wouters BG , Minton NP , Lambin P . (2006) Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo . Br J Cancer . 95 : 1212-9 .
46. Pawelek JM , Low KB , Bermudes D . (1997) Tumor-targeted Salmonella as a novel anticancer vector . Cancer Res . 57 : 4537-44 .
47. Zheng LM , Luo X , Feng M , Li Z , Le T , Ittensohn M , Trailsmith M , Bermudes D , Lin SL , King IC . (2000) Tumor amplified protein expression therapy: Salmonella as a tumor-selective protein delivery vector . Oncol Res . 12 : 127-35 .
48. King I , Bermudes D , Lin S , Belcourt M , Pike J , Troy K , Le T , Ittensohn M , Mao J , Lang W , Runyan JD , Luo X , Li Z , Zheng LM . (2002) Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent . Hum Gene Ther . 13 : 1225-33 .
49. Nakamura T , Sasaki T , Fujimori M , Yazawa K , Kano Y , Amano J , Taniguchi S . (2002) Cloned cytosine deaminase gene expression of Bifidobacterium longum and application to enzyme/pro-drug therapy of hypoxic solid tumors . Biosci Biotechnol Biochem . 66 : 2362-6 .
50. Sasaki T , Fujimori M , Hamaji Y , Hama Y , Ito K , Amano J , Taniguchi S . (2006) Genetically engineered Bifidobacterium longum for tumor-targeting enzyme-prodrug therapy of autochthonous mammary tumors in rats . Cancer Sci . 97 : 649-57 .
51. Hamaji Y , Fujimori M , Sasaki T , Matsuhashi H , Matsui-Seki K , Shimatani-Shibata Y , Kano Y , Amano J , Taniguchi S . (2007) Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy . Biosci Biotechnol Biochem . 71 : 874-83 .
52. Folkman J. (1989) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst . 82 : 4-6 .
53. Kerbel RS , Kamen BA. (2004) The anti-angiogenic basis of metronomic chemotherapy . Nat Rev Cancer . 4 : 423-36
54. Persano L , Crescenzi M , Indraccolo S . (2007) Anti-angiogenic gene therapy of cancer: Current status and future prospects . Mol Aspects Med . 28 : 87-114
55. Lee CH , Wu CL , Shiau AL. (2005) Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model . Cancer Gene Ther . 12 , 175-84
56. Lee CH , Wu CL Shiau AL. (2004) Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models . J Gene Med . 6 , 1382-93
57. Li X , Fu GF , Fan YR , Liu WH , Liu XJ , Wang JJ , Xu GX. (2003) Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth . Cancer Gene Ther. 10 : 105-11 .
58. Fu GF , Li X , Hou YY , Fan YR , Liu WH , Xu GX . (2005) Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer . Cancer Gene Ther . 12 : 133-40 .
59. Eckmann L , Kagnoff MF . (2001) Cytokines in host defense against Salmonella . Microbes Infect . 3 : 1191-4
60. Cao Y. (2001) Endogenous angiogenesis inhibitors and their therapeutic implications . Int J Biochem Cell Biol . 3 3 : 357-69
61. Jia LJ , Xu HM , Ma DY , Hu QG , Huang XF , Jiang WH , Li SF , Jia KZ , Huang QL , Hua ZC . (2005) Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model . Cancer Biol Ther . 4 : 840-5 .
62. Dang LH , Bettegowda C , Agrawal N , Cheong I , Huso D , Frost P , Loganzo F , Greenberger L , Barkoczy J , Pettit GR , Smith AB 3rd , Gurulingappa H , Khan S , Parmigiani G , Kinzler KW , Zhou S , Vogelstein B . (2004) Targeting vascular and avascular compartments of tumors with C. novyi -NT and anti-microtubule agents . Cancer Biol Ther . 3 : 326-37 .
63. Rescigno M , Avogadri F , Curigliano G . (2007) Challenges and prospects of immunotherapy as cancer treatment . Biochim Biophys Acta . 1776 : 108-23 .
64. Podhajcer OL , Lopez MV , Mazzolini G . (2007) Cytokine gene transfer for cancer therapy . Cytokine Growth Factor Rev . 18 : 183-94 .
65. Del Vecchio M , Bajetta E , Canova S , Lotze MT , Wesa A , Parmiani G , Anichini A . (2007) Interleukin-12: Biological properties and clinical application . Clin Cancer Res . 13 : 4677-85 .
66. Theys J , Nuyts S , Landuyt W , Van Mellaert L , Dillen C , Bohringer M , Durre P , Lambin P , Anne J . (1999) Stable Escherichia coli - Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha . Appl Environ Microbiol . 65 : 4295-300 .
67. Nuyts S , Van Mellaert L , Theys J , Landuyt W , Bosmans E , Anne J , Lambin P . (2001) Radio-responsive recA promoter significantly increases TNFalpha production in recombinant clostridia after 2 Gy irradiation . Gene Ther . 8 : 1197-201 .
68. Lin S , Spinka T , Le T , Pianta T , King I , Belcourt F , Li Z. (1999) Tumor-directed delivery and amplification of tumor-necrosis factor-alpha (TNF) by attenuated Salmonella typhimurium . Clin Cancer Res . 5 , 3822
69. Barbe S , Van Mellaert L , Theys J , Geukens N , Lammertyn E , Lambin P , Anne J . (2005) Secretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as a tool for anti-tumor treatment . FEMS Microbiol Lett . 246 : 67-73 .
70. Loeffler M , Le'Negrate G , Krajewska M , Reed JC . (2007) Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth . Proc Natl Acad Sci . 104 : 12879-83 .
71. Iorns E , Lord CJ , Turner N , Ashworth A . (2007) Utilizing RNA interference to enhance cancer drug discovery . Nat Rev Drug Discov . 6 : 556-68 .
72. Kim DH , Rossi JJ. (2007) Strategies for silencing human disease using RNA interference . Nat Rev Genet 8 : 173-84 .
73. Li CX , Parker A , Menocal E , Xiang S , Borodyansky L , Fruehauf JH . (2006) Delivery of RNA interference . Cell Cycle . 5 : 2103-9 .
74. Xiang S , Fruehauf J , Li CJ . (2006) Short hairpin RNA-expressing bacteria elicit RNA interference in mammals . Nat Biotechnol . 24 : 697-702 .
75. Zhang L , Gao L , Zhao L , Guo B , Ji K , Tian Y , Wang J , Yu H , Hu J , Kalvakolanu DV , Kopecko DJ , Zhao X , Xu DQ . 007) Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid- based small interfering RNAs . Cancer Res . 67 : 5859-64 .
76. Sun Y . (2006) E3 ubiquitin ligases as cancer targets and biomarkers . Neoplasia . 8 (8) : 645-54 .
77. Bandres E , Agirre X , Ramirez N , Zarate R , Garcia-Foncillas J . (2007) MicroRNAs as cancer players: Potential clinical and biological effects . DNA Cell Biol . 26 : 273-82 .
78. Esquela-Kerscher A , Slack FJ . (2006) Oncomirs - microRNAs with a role in cancer . Nat Rev Cancer . 6 : 259-69 .
79. Yu YA , Shabahang S , Timiryasova TM , Zhang Q , Beltz R , Gentschev I , Goebel W , Szalay AA . (2004) Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins . Nat Biotechnol . 22 : 313-20 .
80. Stritzker J , Weibel S , Hill PJ , Oelschlaeger TA , Goebel W , Szalay AA . (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice . Int J Med Microbiol . 297 : 151-62 .
81. Zhao M , Yang M , Li XM , Jiang P , Baranov E , Li S , Xu M , Penman S , Hoffman RM . (2005) Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium . Proc Natl Acad Sci . 102 : 755-60 .
82. Low KB , Ittensohn M , Le T , Platt J , Sodi S , Amoss M , Ash O , Carmichael E , Chakraborty A , Fischer J , Lin SL , Luo X , Miller SI , Zheng L , King I , Pawelek JM , Bermudes D . (1999) Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo . Nat Biotechnol . 17 : 37-41 .
83. Pawelek JM , Sodi S , Chakraborty AK , Platt JT , Miller S , Holden DW , Hensel M , Low KB . (2002) Salmonella pathogenicity island-2 and anticancer activity in mice . Cancer Gene Ther . 9 : 813-8 .
84. Lee CH , Wu CL , Tai YS , Shiau AL . (2005) Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy . Mol Ther . 11 : 707-16 .
85. Theys J , Landuyt W , Nuyts S , Van Mellaert L , Bosmans E , Rijnders A , Van Den Bogaert W , Van Oosterom A , Anne J , Lambin P . (2001) Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas . FEMS Immunol Med Microbiol . 30 : 37-41 .
86. Bereta M , Hayhurst A , Gajda M , Chorobik P , Targosz M , Marcinkiewicz J , Kaufman HL . (2007) Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies . Vaccine . 25 : 4183-92 .
87. Jaracz S , Chen J , Kuznetsova LV , Ojima I . (2005) Recent adVances in tumor-targeting anticancer drug conjugates . Bioorg Med Chem . 13 : 5043-54 .
88. Mori T . (2004) Cancer-specific ligands identified from screening of peptide-display libraries . Curr Pharm Des . 10 : 2335-43 .
89. Schmidt FR . (2004) Recombinant expression systems in the pharmaceutical industry . Appl Microbiol Biotechnol . 65 : 363-72 .
90. Rana TM . (2007) Illuminating the silence: understanding the structure and function of small RNAs . Nat Rev Mol Cell Biol . 8 : 23-36 .
91. Palumbo RN , Wang C . (2006) Bacterial invasin: Structure, function, and implication for targeted oral gene delivery . Curr Drug Deliv . 3 : 47-53 .
92. Anderson JC , Clarke EJ , Arkin AP , Voigt CA . (2006) Environmentally controlled invasion of cancer cells by engineered bacteria . J Mol Biol . 355 : 619-27 .
93. Xu F , Ulmer JB . (2003) Attenuated salmonella and Shigella as carriers for DNA vaccines . J Drug Target . 11 : 481-8 .
94. rLoessner H, Endmann A, Leschner S, Bauer H, Zelmer A, Zur Lage S, Westphal K, Weiss S. (2008) Improving live attenuated bacterial carriers for vaccination and therapy. Int J Med Microbiol. 298:21-6.
95. Hess J , Gentschev I , Miko D , Welzel M , Ladel C , Goebel W , Kaufmann SH . (1996) Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis . Proc Natl Acad Sci. USA . 93 : 1458-63 .
96. Gentschev I , Dietrich G , Spreng S , Kolb- Maurer A , Brinkmann V , Grode L , Hess J , Kaufmann SH , Goebel W . (2001) Recombinant attenuated bacteria for the delivery of subunit vaccines . Vaccine . 19 : 2621-8 .
97. Goussard S , Grillot-Courvalin C , Courvalin P . (2003) Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria . J Mol Microbiol Biotechnol . 6 : 211-8 .
98. Nuyts S , Van Mellaert L , Theys J , Landuyt W , Lambin P , Anne J . (2001) The use of radiation- induced bacterial promoters in anaerobic conditions: A means to control gene expression in clostridium-mediated therapy for cancer . Radiat Res . 155 : 716-23 .
99. Mengesha A , Dubois L , Lambin P , Landuyt W , Chiu RK , Wouters BG , Theys J . (2006) Development of a flexible and potent hypoxia- inducible promoter for tumor-targeted gene expression in attenuated Salmonella . Cancer Biol Ther . 5 : 1120-8 .
100. Weber W , Fussenegger M . (2006) Pharmacologic transgene control systems for gene therapy . J Gene Med . 8 : 535-56 .
101. Loessner H , Endmann A , Leschner S , Westphal K , Rohde M , Miloud T , Hammerling G , Neuhaus K , Weiss S . (2007) Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo . Cell Microbiol . 9 : 1529-37 .
102. Scott SD , Greco O . (2004) Radiation and hypoxia inducible gene therapy systems . Cancer Metastasis Rev . 23 : 269-76 .
103. Mezhir JJ , Schmidt H , Yamini B , Senzer NN , Posner MC , Kufe DW , Weichselbaum RR . (2005) Chemo-inducible gene therapy . Anticancer Drugs . 16 : 1053-8 .
104. Jia LJ , Wei DP , Sun QM , Huang Y , Wu Q , Hua ZC . (2007) Oral delivery of tumor-targeting Salmonella for cancer therapy in murine tumor models . Cancer Sci . 98 : 1107-12 .
105. Luo Y , Zhou H , Mizutani M , et al . (2003) Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine . Proc Natl Acad Sci USA . 100 : 8850-5 .
106. Luo Y , Zhou H , Mizutani M , et al . (2005) A DNA vaccine targeting Fos-related antigen 1enhanced by IL-18 induces long-lived T-cell memory against tumor recurrence . Cancer Res . 65 : 3419-27 .
107. Echeverri CJ , Perrimon N . (2006) Highthroughput RNAi screening in cultured cells: A user's guide . Nat Rev Genet . 7 : 373-84 .
108. Ngo VN , Davis RE , Lamy L , Yu X , Zhao H , Lenz G , Lam LT , Dave S , Yang L , Powell J , Staudt LM . (2006) A loss-of-function RNA interference screen for molecular targets in cancer . Nature . 441 : 106-10 .